The Scientist

» organ transplant and disease/medicine

Most Recent

image: Pluripotency Bots

Pluripotency Bots

By | January 1, 2016

A tour of efforts to automate the production and differentiation of induced pluripotent stem cells

0 Comments

image: Hearts in Hand

Hearts in Hand

By | January 1, 2016

Texas Heart Institute heart surgeon Bud Frazier is a pioneer of heart transplant technologies.

0 Comments

image: If It Ain't Broke . . .

If It Ain't Broke . . .

By | January 1, 2016

Is there room to improve upon the tried-and-true, decades-old technology of artificial hearts?

0 Comments

image: Picking Up the Pace

Picking Up the Pace

By | January 1, 2016

FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.

0 Comments

image: Viral Soldiers

Viral Soldiers

By | January 1, 2016

Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.

11 Comments

image: Second Contagious Cancer Found in Tasmanian Devils

Second Contagious Cancer Found in Tasmanian Devils

By | December 29, 2015

A second fatal, transmissible cancer has been identified in the already endangered species.  

0 Comments

image: Year in Review: Hot Topics

Year in Review: Hot Topics

By | December 21, 2015

In 2015, The Scientist dove deep into the latest research on aging, HIV, hearing, and obesity.

0 Comments

image: When the Flu Vax Fails

When the Flu Vax Fails

By | December 16, 2015

The status of a person’s immune system can predict when a seasonal flu vaccination will not provide sufficient protection, according to a study. 

0 Comments

image: Global Food-Related Disease Estimate

Global Food-Related Disease Estimate

By | December 7, 2015

More than 400,000 people—including 125,000 children—die from foodborne illness every year, according to the World Health Organization.

0 Comments

image: The Regenerator

The Regenerator

By | December 1, 2015

In his search for effective therapies for Parkinson’s disease, Lorenz Studer is uncovering pluripotency switches and clues to what makes cells age.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech